Registration of securities issued in business combination transactions

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Cumulative Effect, Period of Adoption, Adjustment
Legacy Convertible Preferred Stock
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Cumulative Effect, Period of Adoption, Adjustment
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive (Loss) Income
Cumulative Effect, Period of Adoption, Adjusted Balance
Notes Receivable
Cumulative Effect, Period of Adoption, Adjusted Balance
Legacy Convertible Preferred Stock
Series E Preferred Stock
Common Stock
Series E Preferred Stock
Additional Paid-In Capital
Series E Preferred Stock
Series E1 Preferred Stock
Common Stock
Series E1 Preferred Stock
Additional Paid-In Capital
Series E1 Preferred Stock
Common Stock
In-process research and development
Common Stock
Additional Paid-In Capital
In-process research and development
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Notes Receivable
In-process research and development
Total
BALANCE at Dec. 31, 2018 $ (276,889)                   $ 276,889                              
BALANCE (in shares) at Dec. 31, 2018 (84,092,669)                   84,092,669                              
BALANCE at Dec. 31, 2019 $ (436,533)                   $ 436,533                              
BALANCE (in shares) at Dec. 31, 2019 (100,038,109)                   100,038,109                              
Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests [Abstract]                                                    
Issuance of Preferred Stock (in shares)                       16,426,267     3,046,623                      
Issuance of Preferred Stock                       $ 2 $ 134,665 $ 134,667   $ 24,977 $ 24,977                  
BALANCE at Dec. 31, 2018   $ 11 $ 276,878 $ 276,889 $ 13 $ 283,318 $ (190,666) $ (96) $ (249) $ 92,320                 $ 2   $ 6,440 $ (190,666) $ (96) $ (249)   $ (184,569)
BALANCE (in shares) at Dec. 31, 2018   106,977,440     126,329,695                           19,352,255              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                    
Exercise of Common Stock options                                         708         708
Exercise of Common Stock options (in shares)                                     1,217,255              
Vesting of restricted Common Stock                                     $ 1   7         8
Vesting of restricted Common Stock (in shares)                                     6,904,182              
Issuance of Common Stock for acquisitions                                         3,563         3,563
Issuance of Common Stock for acquisitions (in shares)                                     1,066,373              
Issuance of common stock for acquired in-process research and development                                                   3,563
Stock-based compensation expense                                         5,215         5,215
Common Stock warrants issued                                         1,038         1,038
Net loss                                           (103,596)       (103,596)
Other comprehensive income (loss)                                             171     171
BALANCE at Dec. 31, 2019   $ 13 436,520 436,533 $ 16 453,242 (294,262) 75   159,071                 $ 3   16,722 (294,262) 75     (277,462)
BALANCE (in shares) at Dec. 31, 2019   128,100,821     154,913,934                           26,813,113              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                    
Repayment of notes receivable                                         (249)     $ 249    
Repayment of notes receivable (in shares)                                     (76,461)              
Exercise of Common Stock options                                         136         136
Exercise of Common Stock options (in shares)                                     314,809              
Vesting of restricted Common Stock                                         4         4
Vesting of restricted stock units (in shares)                                     3,500,915              
Stock-based compensation expense                                         2,333         2,333
Common Stock warrants issued                                         211         211
Net loss                                           (45,570)       (45,570)
Other comprehensive income (loss)                                             (27)     (27)
BALANCE at Jun. 30, 2020                                     $ 16   455,926 (339,832) 48     $ 116,158
BALANCE (in shares) at Jun. 30, 2020                                     158,729,658              
BALANCE at Dec. 31, 2019 $ (436,533)                   $ 436,533                              
BALANCE (in shares) at Dec. 31, 2019 (100,038,109)                   100,038,109                              
BALANCE (in shares) at Dec. 31, 2020                                                   100,038,109
BALANCE at Dec. 31, 2019   $ 13 436,520 436,533 $ 16 453,242 (294,262) 75   159,071                 $ 3   16,722 (294,262) 75     $ (277,462)
BALANCE (in shares) at Dec. 31, 2019   128,100,821     154,913,934                           26,813,113              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                    
Exercise of Common Stock options                                         325         325
Exercise of Common Stock options (in shares)                                     521,925              
Vesting of restricted Common Stock                                     $ 1   6         7
Vesting of restricted Common Stock (in shares)                                     5,307,357              
Repurchase of shares for employee tax withholdings (in shares)                                     (9,308)              
Issuance of Common Stock for acquisitions                                         500         500
Issuance of Common Stock for acquisitions (in shares)                                     61,060              
Issuance of common stock for acquired in-process research and development                                                   500
Stock-based compensation expense                                         8,006         8,006
Common Stock warrants issued                                         1,915         1,915
Common Stock warrants issued (in shares)                                     692,366              
Net loss                                           (34,015)       (34,015)
Other comprehensive income (loss)                                             (84)     (84)
BALANCE at Dec. 31, 2020                                     $ 23   844,188 (328,277) (9)     515,925
BALANCE (in shares) at Dec. 31, 2020                                     224,626,597              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                    
Reverse recapitalization, net of transaction costs                                     $ 6   380,295         380,301
Reverse recapitalization, net of transaction costs (in shares)                                     63,139,263              
BALANCE at Mar. 31, 2020 $ (436,533)                   $ 436,533                              
BALANCE (in shares) at Mar. 31, 2020 (100,038,109)                   100,038,109                              
BALANCE at Mar. 31, 2020   $ 13 $ 438,037 $ 438,050 $ 16 $ 454,759 $ (316,066) $ (84)   $ 138,625                 $ 3   16,722 (316,066) (84)     (299,425)
BALANCE (in shares) at Mar. 31, 2020   130,138,012     156,951,125                           26,813,113              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                    
Exercise of Common Stock options                                         4         4
Exercise of Common Stock options (in shares)                                     28,173              
Vesting of restricted Common Stock                                         2         2
Vesting of restricted Common Stock (in shares)                                     1,750,360              
Stock-based compensation expense                                         1,074         1,074
Common Stock warrants issued                                         87         87
Net loss                                           (23,766)       (23,766)
Other comprehensive income (loss)                                             132     132
BALANCE at Jun. 30, 2020                                     $ 16   455,926 (339,832) 48     $ 116,158
BALANCE (in shares) at Jun. 30, 2020                                     158,729,658              
BALANCE (in shares) at Dec. 31, 2020                                                   100,038,109
BALANCE at Dec. 31, 2020                                     $ 23   844,188 (328,277) (9)     $ 515,925
BALANCE (in shares) at Dec. 31, 2020                                     224,626,597              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                    
Exercise of Common Stock options                                         3,665         3,665
Exercise of Common Stock options (in shares)                                     2,846,734              
Vesting of restricted Common Stock (in shares)                                     112,030              
Vesting of restricted stock units (in shares)                                     43,921              
Repurchase of shares for employee tax withholdings                                         (145)         (145)
Repurchase of shares for employee tax withholdings (in shares)                                     (9,172)              
Issuance of Common Stock for acquisitions                                     $ 1   208,988         208,989
Issuance of Common Stock for acquisitions (in shares)                                     9,049,338              
Issuance of common stock for acquired in-process research and development                                       $ 4,300         $ 4,300  
Issuance of common stock for acquired in-process research and development (in shares)                                   334,370                
Stock-based compensation expense                                         6,216         6,216
Vesting of Trine Founder shares (in shares)                                     1,850,938              
Exercise of warrants                                     $ 2   320,567         320,569
Exercise of warrants (in shares)                                     20,690,975              
Net loss                                           (102,288)       (102,288)
Other comprehensive income (loss)                                             113     113
BALANCE at Jun. 30, 2021                                     $ 26   1,387,779 (430,565) 104     957,344
BALANCE (in shares) at Jun. 30, 2021                                     259,545,731              
BALANCE at Mar. 31, 2021                                     $ 25   1,326,945 (387,385) (21)     939,564
BALANCE (in shares) at Mar. 31, 2021                                     252,436,919              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                    
Exercise of Common Stock options                                         3,485         3,485
Exercise of Common Stock options (in shares)                                     2,683,506              
Vesting of restricted Common Stock (in shares)                                     56,015              
Vesting of restricted stock units (in shares)                                     28,656              
Repurchase of shares for employee tax withholdings                                         (91)         (91)
Repurchase of shares for employee tax withholdings (in shares)                                     (6,931)              
Issuance of Common Stock for acquisitions                                     $ 1   49,141         49,142
Issuance of Common Stock for acquisitions (in shares)                                     4,013,196              
Issuance of common stock for acquired in-process research and development                                       $ 4,300         $ 4,300  
Issuance of common stock for acquired in-process research and development (in shares)                                   334,370                
Stock-based compensation expense                                         3,999         3,999
Net loss                                           (43,180)       (43,180)
Other comprehensive income (loss)                                             125     125
BALANCE at Jun. 30, 2021                                     $ 26   $ 1,387,779 $ (430,565) $ 104     $ 957,344
BALANCE (in shares) at Jun. 30, 2021                                     259,545,731